854 related articles for article (PubMed ID: 8035312)
1. Ligand specificity of nicotinic acetylcholine receptors in rat spinal cord: studies with nicotine and cytisine.
Khan IM; Yaksh TL; Taylor P
J Pharmacol Exp Ther; 1994 Jul; 270(1):159-66. PubMed ID: 8035312
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and behavioral responses to nicotinic agents administered intrathecally.
Khan IM; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1994 Jul; 270(1):150-8. PubMed ID: 8035311
[TBL] [Abstract][Full Text] [Related]
3. [3H]cytisine binding to nicotinic cholinergic receptors in brain.
Pabreza LA; Dhawan S; Kellar KJ
Mol Pharmacol; 1991 Jan; 39(1):9-12. PubMed ID: 1987453
[TBL] [Abstract][Full Text] [Related]
4. Regulation of human alpha4beta2 neuronal nicotinic acetylcholine receptors by cholinergic channel ligands and second messenger pathways.
Gopalakrishnan M; Molinari EJ; Sullivan JP
Mol Pharmacol; 1997 Sep; 52(3):524-34. PubMed ID: 9281615
[TBL] [Abstract][Full Text] [Related]
5. Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine alpha 4 beta 2 receptor.
Gopalakrishnan M; Monteggia LM; Anderson DJ; Molinari EJ; Piattoni-Kaplan M; Donnelly-Roberts D; Arneric SP; Sullivan JP
J Pharmacol Exp Ther; 1996 Jan; 276(1):289-97. PubMed ID: 8558445
[TBL] [Abstract][Full Text] [Related]
6. Nicotinic receptor binding of [3H]cytisine, [3H]nicotine and [3H]methylcarbamylcholine in rat brain.
Anderson DJ; Arneric SP
Eur J Pharmacol; 1994 Mar; 253(3):261-7. PubMed ID: 8200419
[TBL] [Abstract][Full Text] [Related]
7. Characterization of [3H]ABT-418: a novel cholinergic channel ligand.
Anderson DJ; Williams M; Pauly JR; Raszkiewicz JL; Campbell JE; Rotert G; Surber B; Thomas SB; Wasicak J; Arneric SP
J Pharmacol Exp Ther; 1995 Jun; 273(3):1434-41. PubMed ID: 7791118
[TBL] [Abstract][Full Text] [Related]
8. Ablation of primary afferent terminals reduces nicotinic receptor expression and the nociceptive responses to nicotinic agonists in the spinal cord.
Khan IM; Wennerholm M; Singletary E; Polston K; Zhang L; Deerinck T; Yaksh TL; Taylor P
J Neurocytol; 2004 Sep; 33(5):543-56. PubMed ID: 15906161
[TBL] [Abstract][Full Text] [Related]
9. Antinociceptive responses to nicotinic acetylcholine receptor ligands after systemic and intrathecal administration in mice.
Damaj MI; Fei-Yin M; Dukat M; Glassco W; Glennon RA; Martin BR
J Pharmacol Exp Ther; 1998 Mar; 284(3):1058-65. PubMed ID: 9495867
[TBL] [Abstract][Full Text] [Related]
10. (S)-3-methyl-5-(1-methyl-2-pyrrolidinyl) isoxazole (ABT 418): a novel cholinergic ligand with cognition-enhancing and anxiolytic activities: I. In vitro characterization.
Arneric SP; Sullivan JP; Briggs CA; Donnelly-Roberts D; Anderson DJ; Raszkiewicz JL; Hughes ML; Cadman ED; Adams P; Garvey DS
J Pharmacol Exp Ther; 1994 Jul; 270(1):310-8. PubMed ID: 7518514
[TBL] [Abstract][Full Text] [Related]
11. C3-halogenation of cytisine generates potent and efficacious nicotinic receptor agonists.
Abin-Carriquiry JA; Voutilainen MH; Barik J; Cassels BK; Iturriaga-Vásquez P; Bermudez I; Durand C; Dajas F; Wonnacott S
Eur J Pharmacol; 2006 Apr; 536(1-2):1-11. PubMed ID: 16563372
[TBL] [Abstract][Full Text] [Related]
12. Positive feedback modulation of acetylcholine release from isolated rat superior cervical ganglion.
Liang SD; Vizi ES
J Pharmacol Exp Ther; 1997 Feb; 280(2):650-5. PubMed ID: 9023275
[TBL] [Abstract][Full Text] [Related]
13. In vitro evidence and age-related changes for nicotinic but not muscarinic acetylcholine receptors in the central nervous system of Sepia officinalis.
Bellanger C; Halm MP; Dauphin F; Chichery R
Neurosci Lett; 2005 Oct; 387(3):162-7. PubMed ID: 16026931
[TBL] [Abstract][Full Text] [Related]
14. A subtype of nicotinic cholinergic receptor in rat brain is composed of alpha 4 and beta 2 subunits and is up-regulated by chronic nicotine treatment.
Flores CM; Rogers SW; Pabreza LA; Wolfe BB; Kellar KJ
Mol Pharmacol; 1992 Jan; 41(1):31-7. PubMed ID: 1732720
[TBL] [Abstract][Full Text] [Related]
15. N-n-alkylnicotinium analogs, a novel class of nicotinic receptor antagonists: interaction with alpha4beta2* and alpha7* neuronal nicotinic receptors.
Wilkins LH; Grinevich VP; Ayers JT; Crooks PA; Dwoskin LP
J Pharmacol Exp Ther; 2003 Jan; 304(1):400-10. PubMed ID: 12490617
[TBL] [Abstract][Full Text] [Related]
16. Release of [3H]-noradrenaline from rat hippocampal synaptosomes by nicotine: mediation by different nicotinic receptor subtypes from striatal [3H]-dopamine release.
Clarke PB; Reuben M
Br J Pharmacol; 1996 Feb; 117(4):595-606. PubMed ID: 8646402
[TBL] [Abstract][Full Text] [Related]
17. Stimulatory pathways and sites of action of intrathecally administered nicotinic agents.
Khan IM; Taylor P; Yaksh TL
J Pharmacol Exp Ther; 1994 Dec; 271(3):1550-7. PubMed ID: 7996469
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological characterization of neuronal acetylcholine gated ion channel receptor-mediated hippocampal norepinephrine and striatal dopamine release from rat brain slices.
Sacaan AI; Dunlop JL; Lloyd GK
J Pharmacol Exp Ther; 1995 Jul; 274(1):224-30. PubMed ID: 7542334
[TBL] [Abstract][Full Text] [Related]
19. Nicotinic receptor binding sites in rat primary neuronal cells in culture: characterization and their regulation by chronic nicotine.
Dávila-García MI; Houghtling RA; Qasba SS; Kellar KJ
Brain Res Mol Brain Res; 1999 Mar; 66(1-2):14-23. PubMed ID: 10095073
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic receptor function determined by stimulation of rubidium efflux from mouse brain synaptosomes.
Marks MJ; Farnham DA; Grady SR; Collins AC
J Pharmacol Exp Ther; 1993 Feb; 264(2):542-52. PubMed ID: 8437106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]